A proton beam is a form of focused radiation used to treat solid tumors. It is superior to traditional radiation therapy (X-Ray, or Photons) in that it reduces damage to surrounding healthy tissue by 2X-6X, thereby reducing toxicities and improving patient survival and quality of life. Proton therapy is used routinely for treating many types of cancer; it is FDA-cleared (510k) and reimbursed by both Federal and private insurers.
Proton beam therapy can help 300,000 cancer patients/year (US) – yet only 8,000 receive it; that’s less than 3%.
Protons are arguably the most advanced form of radiation therapy – yet there are only 61 proton-therapy centers world-wide; compare with over 10,000 X-Ray radiation therapy machines.
The main barrier to widespread adoption is the large size (football stadium) and high cost ($150-250M) of building and operating a center. Single-room solutions are slowly being introduced by some vendors for a total cost of $30-45M to the hospital.
The key to making protons available to every patient is a scalable, add-on, single-room solution, at less than half the current price tag; all while maintaining very high beam quality and providing cutting-edge clinical capabilities such as PBS, IMPT, and more.
HIL’s technological breakthrough promises to bring about this revolution.